Medical technologies are playing an increasing role in diagnosis, treatment and rehabilitation of our patients. At the NHCS, we have expertise in the evaluation of several novel medical technologies, including class 2 and class 3 implantable Medical Devices. Several of our clinicians and researchers have also developed in-house new devices, bio-therapeutics tools and software for cardiovascular diseases treatment.
Our objective is to foster Medtech translational research at NHRIS-NHCS. NHCS has a number of research collaborations with academic (A*STAR, Duke-NUS, NTU, NUS-NUHS) and industry partners. At NHCS, our clinicians have also an extensive experience conducting clinical evaluation of new medical technologies, including novel treatments for Coronary Artery Diseases (CAD), aortic and mitral valve therapy, cardiac rhythm management, diagnostic imaging, Digital Health/remote monitoring.
The experience in basic and clinical research enables us to be at the forefront of Medtech innovation and therapeutic treatments for Heart Diseases.
Subscribe to our mailing list to get the updates to your email inbox...